Jeffrey W. Albers Aeglea Bio Therapeutics, Inc. (AGLE) insider trading activity

AGLE Quotes by TradingView

Jeffrey W. Albers Transaction History

Date Transaction Value Shares Traded Form
Nov 06 2024
SELL
Open market or private sale
$246,292 $36.76 p/Share
6,700
Oct 25 2024
SELL
Open market or private sale
$10,929 $36.43 p/Share
300

Also insider at

BPMC
Blueprint Medicines Corp Healthcare
MGTA
Magenta Therapeutics, Inc. Healthcare
Director
KYMR
Kymera Therapeutics, Inc. Healthcare
JWA

Jeffrey W. Albers

Director
Cambridge, MA

Track Institutional and Insider Activities on AGLE

Follow Aeglea BioTherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGLE shares.

Notify only if

Insider Trading

Get notified when an Aeglea Bio Therapeutics, Inc. insider buys or sells AGLE shares.

Notify only if

News

Receive news related to Aeglea BioTherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGLE